Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyVAC Bangladesh typhoid vaccine trial
ISRCTN11643110Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Typbar-TCV in typhoid fever (4 arms), sponsored by University of Oxford. Primary endpoint: Efficacy against blood culture-confirmed typhoid fever in vaccinees. Started Feb 2018; status: completed.
02
Drugs
Typbar-TCV
03
Conditions
typhoid fever
Beyond the preview
Go deeper on ISRCTN11643110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11643110.